Postoperative Follow-up of Asymptomatic Papillary Microcarcinomas on Patient Survival

N/AActive Not RecruitingNCT05873361

University Hospital, Toulouse500 enrolled

Overview

This is a study assessing the interest of post-operative follow-up of asymptomatic papillary microcarcinomas. Today, this post-operative follow-up represents an economic cost and is a source of anxiety for patients. The aim of this study is to determine the global survival of patients with asymptomatic papillary microcarcinoma to assess the interest of a post-operative ultrasound and/or biological follow-up.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Papillary Carcinoma

Interventions

QuestionnaireOTHER

The questionnaire is about hypocalcemia, dysphonia and anxiety. It will be carried out by phone call for 10 minutes

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with uni or multifocal papillary microcarcinoma (cumulative size of foci \<10mm) asymptomatic or not and who underwent partial or total thyroidectomy from 2012 to 2017. * Non opposition patient * Affiliation to a social security scheme Exclusion Criteria: * Lesion crossing the thyroid capsule, or cervical lymph node involvement clinical or histological cervical lymph node involvement. * Patient under guardianship, curators or safeguard of justice

Locations (1)

UHToulouse

Toulouse, France

Outcomes

Primary Outcomes

Overall survival

Review of medical record

Time frame: 10 years

Secondary Outcomes

Disease control rate

No recurrence clinically detected or by additional examen

Time frame: 10 years

Surgical complications rate

Dysphonia and hypocalcemia

Time frame: 10 years

Detection of recurrence rate

Recurrence detection by additional examen

Time frame: 10 years

Recovery surgical or iratherapie recovery rate

Anatomopathologic analysis

Time frame: 10 years

Anxiety evaluation

Likert scale

Time frame: 1 month

Prognostics survival criteria

Age during surgical

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.